Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Mykoliuk, I; Maier, A; Lindenmann, J; Smolle-Jüttner, FM.
[SARS-CoV-2-associated pneumothorax, pneumomediastinum and soft tissue emphysema. Clinical implications based on a case series].
Wien Med Wochenschr. 2022; 172(3-4):84-89
Doi: 10.1007/s10354-021-00872-4
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Mykoliuk Iurii
- Co-Autor*innen der Med Uni Graz
- Lindenmann Jörg
- Maier Alfred
- Smolle-Juettner Freyja-Maria
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The new coronavirus (SARS-CoV-2) that arose in 2019 causes a wide spectrum of symptoms and different courses of disease. Pneumothorax, pneumomediastinum and soft tissue emphysema are rare complications in patients with pulmonary involvement. They are the sequelae of severe, virus-induced structural changes of the pulmonary architecture. High pressure artificial ventilation aggravates the problem. Hence pneumothorax and ectopic air in soft tissues are indicators of extensive pulmonary damage. Therefore, efforts should be made to treat even very small or multiply recurrent pneumothorax by drainage procedures.
- Find related publications in this database (using NLM MeSH Indexing)
- COVID-19 - complications
- Humans - administration & dosage
- Mediastinal Emphysema - diagnostic imaging, etiology, therapy
- Pneumothorax - diagnostic imaging, etiology, therapy
- SARS-CoV-2 - administration & dosage
- Subcutaneous Emphysema - diagnostic imaging, etiology, therapy
- Find related publications in this database (Keywords)
- Coronavirus
- SARS-CoV-2
- Pneumothorax
- Pneumomediastinum
- Soft tissue emphysema